<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31332433</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>2230</StartPage><EndPage>2237</EndPage><MedlinePgn>2230-2237</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awz182</ELocationID><Abstract><AbstractText>Superoxide dismutase 1 (SOD1) is the principal cytoplasmic superoxide dismutase in humans and plays a major role in redox potential regulation. It catalyses the transformation of the superoxide anion (O2&#x2022;-) into hydrogen peroxide. Heterozygous variants in SOD1 are a common cause of familial amyotrophic lateral sclerosis. In this study we describe the homozygous truncating variant c.335dupG (p.C112Wfs*11) in SOD1 that leads to total absence of enzyme activity. The resulting phenotype is severe and marked by progressive loss of motor abilities, tetraspasticity with predominance in the lower extremities, mild cerebellar atrophy, and hyperekplexia-like symptoms. Heterozygous carriers have a markedly reduced enzyme activity when compared to wild-type controls but show no overt neurologic phenotype. These results are in contrast with the previously proposed theory that a loss of function is the underlying mechanism in SOD1-related motor neuron disease and should be considered before application of previously proposed SOD1 silencing as a treatment option for amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Julien H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elpers</LastName><ForeName>Christiane</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reunert</LastName><ForeName>Janine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCormick</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CeGaT GmbH und Praxis f&#xfc;r Humangenetik T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biskup</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CeGaT GmbH und Praxis f&#xfc;r Humangenetik T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rust</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xfc;neberg</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seelh&#xf6;fer</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schara</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boltshauser</LastName><ForeName>Eugen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, University Children's Hospital, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spitz</LastName><ForeName>Douglas R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marquardt</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA182804</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Brain. 2020 Feb 1;143(2):e11</RefSource><PMID Version="1">31960034</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Brain. 2020 Feb 1;143(2):e12</RefSource><PMID Version="1">31960041</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016368" MajorTopicYN="N">Frameshift Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020271" MajorTopicYN="N">Heredodegenerative Disorders, Nervous System</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">hyperekplexia</Keyword><Keyword MajorTopicYN="N">oxidative damage</Keyword><Keyword MajorTopicYN="N">superoxide dismutase</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31332433</ArticleId><ArticleId IdType="pmc">PMC6658856</ArticleId><ArticleId IdType="doi">10.1093/brain/awz182</ArticleId><ArticleId IdType="pii">5536868</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. . A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2855889</ArticleId><ArticleId IdType="pubmed">20354512</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre JD, Culotta VC. Battles with iron: manganese in oxidative stress protection. J Biol Chem 2012; 287: 13541&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340200</ArticleId><ArticleId IdType="pubmed">22247543</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander MD, Traynor BJ, Miller N, Corr B, Frost E, McQuaid S et al. . &#x201c;True&#x201d; sporadic ALS associated with a novel SOD-1 mutation. Ann Neurol 2002; 52: 680&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12402272</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S, Heath PR, Kirby J, Wharton SB, Cookson MR, Menzies FM et al. . Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J Biol Chem 2003; 278: 6371&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">12475980</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keranen ML et al. . Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119(Pt 4): 1153&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nilsson P, Ala-Hurula V, Keranen ML, Tarvainen I, Haltia T et al. . Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995; 10: 61&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7647793</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nilsson P, Forsgren L, Marklund SL. CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutation. J Neurochem 1998; 70: 715&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">9453566</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CM, Sonis ST, Lee CM, Adkins D, Allen BG, Sun W et al. . Phase 1b/2a trial of the superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavity or oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2018; 100: 427&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6430109</ArticleId><ArticleId IdType="pubmed">29174131</ArticleId></ArticleIdList></Reference><Reference><Citation>Auten RL, Davis JM. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res 2009; 66: 121&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19390491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD et al. . Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J Neurol Neurosurg Psychiatry 2017; 88: 99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136332</ArticleId><ArticleId IdType="pubmed">27261500</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006; 52: 39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC et al. . Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994; 91: 8292&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F, Gernoux G, Sun H, Stock R, Blackwood M, Brown RH Jr et al. . Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Sci Transl Med 2018; 10: eaau6414.</Citation><ArticleIdList><ArticleId IdType="pubmed">30381409</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E et al. . Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998; 281: 1851&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015; 31: 2745&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4528627</ArticleId><ArticleId IdType="pubmed">25851949</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung WH. Unraveling new functions of superoxide dismutase using yeast model system: beyond its conventional role in superoxide radical scavenging. J Microbiol 2017; 55: 409&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">28281199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Laing N, Hurse PV, Brown RH Jr. Toxic mutants in Charcot's sclerosis. Nature 1995; 378: 342&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">7477368</ArticleId></ArticleIdList></Reference><Reference><Citation>Coassin M, Ursini F, Bindoli A. Antioxidant effect of manganese. Arch Biochem Biophys 1992; 299: 330&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">1444472</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995; 676: 25&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">7796176</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau KF et al. . Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet 2007; 16: 2720&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY et al. . Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993; 261: 1047&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H et al. . CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005; 24: 367&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">15531919</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang FC. Antimicrobial actions of reactive oxygen species. mBio 2011; 2: e00141-11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171981</ArticleId><ArticleId IdType="pubmed">21896680</ArticleId></ArticleIdList></Reference><Reference><Citation>Filograna R, Godena VK, Sanchez-Martinez A, Ferrari E, Casella L, Beltramini M et al. . Superoxide dismutase (SOD)-mimetic M40403 is protective in cell and fly models of paraquat toxicity: IMPLICATIONS FOR PARKINSON DISEASE. J Biol Chem 2016; 291: 9257&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861490</ArticleId><ArticleId IdType="pubmed">26953346</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Li Y, Asress SA, Jones DP, Glass JD. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp Neurol 2012; 233: 163&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4068963</ArticleId><ArticleId IdType="pubmed">21963651</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman HJ, Maiorino M, Ursini F. Signaling functions of reactive oxygen species. Biochemistry 2010; 49: 835&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4226395</ArticleId><ArticleId IdType="pubmed">20050630</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 2000; 20: 2534&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridovich I. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J Biol Chem 1997; 272: 18515&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9228011</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 2011; 15: 1583&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3151424</ArticleId><ArticleId IdType="pubmed">21473702</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward LJ, Rodriguez JA, Kim JW, Tiwari A, Goto JJ, Cabelli DE et al. . Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem 2002; 277: 15923&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2007; 28: 154&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins CM, Jung C, Ding H, Xu Z. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J Neurosci 2002; 22: Rc215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758252</ArticleId><ArticleId IdType="pubmed">11886899</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuchi Y, Okada F, Onuma K, Onoda T, Asao H, Kobayashi M et al. . Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production. Biochem J 2007; 402: 219&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1798435</ArticleId><ArticleId IdType="pubmed">17059387</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Bergemalm D, Andersen PM, Gredal O, Brannstrom T, Marklund SL. Inclusions of amyotrophic lateral sclerosis-linked superoxide dismutase in ventral horns, liver, and kidney. Ann Neurol 2008; 63: 671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18409196</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene 2016; 577: 109&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I, Birve A, Berdynski M, Hjertkvist K, Rofougaran R, Nilsson TK et al. . Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives. Amyotroph Lateral Scler Frontotemporal Degener 2017; 18: 457&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28325066</ArticleId></ArticleIdList></Reference><Reference><Citation>LeVine SM. The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med Hypotheses 1992; 39: 271&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">1335545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lushchak VI. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact 2014; 224: 164&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">25452175</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Genet 2009; 18: 4552&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773270</ArticleId><ArticleId IdType="pubmed">19779023</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzuk MM, Dionne L, Guo Q, Kumar TR, Lebovitz RM. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 1998; 139: 4008&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9724058</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ et al. . Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest 2018; 128: 3558&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063493</ArticleId><ArticleId IdType="pubmed">30010620</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH et al. . An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol 2013; 12: 435&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller FL, Song W, Liu Y, Chaudhuri A, Pieke-Dahl S, Strong R et al. . Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med 2006; 40: 1993&#x2013;2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">16716900</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Hogrebe M, Gruneberg M, DuChesne I, von der Heiden AL, Reunert J et al. . SLC39A8 deficiency: a disorder of manganese transport and glycosylation. Am J Hum Genet 2015; 97: 894&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4678430</ArticleId><ArticleId IdType="pubmed">26637979</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry JJ, Shin DS, Getzoff ED, Tainer JA. The structural biochemistry of the superoxide dismutases. Biochim Biophys Acta 2010; 1804: 245&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098211</ArticleId><ArticleId IdType="pubmed">19914407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T, Corson LB, Strain J, Wong P, Cleveland DW, Culotta VC et al. . Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet 1999; 8: 1451&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">10400992</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF et al. . Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996; 13: 43&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A et al. . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RK, Fisher EM, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 2013; 136(Pt 8): 2342&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakellariou GK, McDonagh B, Porter H, Giakoumaki II, Earl KE, Nye GA et al. . Comparison of whole body SOD1 knockout with muscle-specific SOD1 knockout mice reveals a role for nerve redox signaling in regulation of degenerative pathways in skeletal muscle. Antioxid Redox Signal 2018; 28: 275&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5743036</ArticleId><ArticleId IdType="pubmed">29065712</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014; 11: 361&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24681721</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Reaume AG, Flood DG, Scott RW, Kowall NW, Ferrante RJ et al. . Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 1999; 53: 1239&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">10522879</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989; 179: 8&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">2547324</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitz DR, Oberley LW. Measurement of MnSOD and CuZnSOD activity in mammalian tissue homogenates. Curr Protoc Toxicol 2001; Chapter 7: Unit7.5. doi: 10.1002/0471140856.tx0705s08.</Citation><ArticleIdList><ArticleId IdType="pubmed">20954153</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica L, Todeasa SH, Cabrera GT, Salameh JS, ElMallah MK, Mueller C et al. . Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. Ann Neurol 2016; 79: 687&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5374859</ArticleId><ArticleId IdType="pubmed">26891182</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumiel I. Autophagy, reactive oxygen species and the fate of mammalian cells. Free Radic Res 2011; 45: 253&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">20964552</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM, Gowing G, Latter J, Chen M, Vit JP, Staggenborg K et al. . Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J Neurosci 2014; 34: 15587&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298650</ArticleId><ArticleId IdType="pubmed">25411487</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 1996; 93: 3155&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC39778</ArticleId><ArticleId IdType="pubmed">8610185</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, Brown RH Jr. Silencing strategies for therapy of SOD1-mediated ALS. Neurosci Lett 2017; 636: 32&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27507699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayvergiya C, Beal MF, Buck J, Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci 2005; 25: 2463&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725162</ArticleId><ArticleId IdType="pubmed">15758154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Jiang Z, Lei XG. Knockout of SOD1 alters murine hepatic glycolysis, gluconeogenesis, and lipogenesis. Free Radic Biol Med 2012; 53: 1689&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472123</ArticleId><ArticleId IdType="pubmed">22974764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg psychiatry 2017; 88: 540&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>